U.S. market Closed. Opens in 5 hours 55 minutes

TMDX | TransMedics Group, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-282018-12-312017-12-312016-12-31
Revenue241.62M93.46M30.26M25.64M23.60M13.02M7.68M6.21M
Cost of Revenue87.63M28.19M9.10M9.00M9.74M7.28M5.55M5.44M
Gross Profit153.99M65.27M21.16M16.64M13.86M5.73M2.14M766.00K
Operating Expenses153.51M96.71M60.59M43.02M43.47M25.97M22.56M23.75M
Selling, General & Admin117.45M69.90M38.28M24.19M23.60M12.31M7.61MN/A
Research & Development36.05M26.81M22.30M18.83M19.87M13.66M14.96M15.64M
Other Operating Expenses47.00K-1.00M-877.00K1.65M790.00K-213.00KN/A8.12M
Operating Income485.00K-31.44M-39.43M-26.38M-29.60M-20.24M-20.43M-22.99M
Other Expenses / Income-27.16M-4.73M-4.75M-2.33M-3.90M-758.00K-365.00K-1.08M
Before Tax Income-26.67M-36.16M-44.18M-28.72M-33.51M-23.71M-20.79M-24.07M
Income Tax Expenses-1.64M66.00K36.00K32.00K40.00K41.00K32.00KN/A
Net Income-25.03M-36.23M-44.22M-28.75M-33.55M-23.76M-20.82M-24.07M
Interest Expenses10.79M3.73M3.87M3.98M4.35M2.72M1.07M979.00K
Basic Shares Outstanding32.52M29.56M27.62M24.70M14.20M19.25M14.48M14.48M
Diluted Shares Outstanding32.52M29.56M27.62M24.70M14.20M19.25M14.48M14.48M
EBITDA8.76M-32.44M-40.30M-24.73M-28.81M-19.68M-19.09M-22.66M
EBITDA Margin3.63%-34.71%-133.19%-96.46%-122.07%-151.19%-248.39%-364.95%
EBIT-15.88M-32.44M-40.30M-24.73M-29.15M-21.00M-19.72M-23.09M
EBIT Margin-6.57%-34.71%-133.19%-96.46%-123.51%-161.29%-256.59%-371.82%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-282018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙